MGMT and glioblastoma: As hypothesized the MGMT promoter methylation degree of the analyzed glioblastoma samples was significantly correlated with the genotypes of the MGMT C-56 T polymorphism (Figure2A; Wilcoxon test, p-value = 0.02), showing a higher methylation level in patients with the T allele.